Structures by: Lari A.
Total: 27
2-Hydroxy-1,1-dimethyl-1,2-dihydrobenzo[cd]indol-1-ium chloride
C13H14NO,Cl
Organic & biomolecular chemistry (2012) 10, 38 7763-7779
a=9.9646(4)Å b=11.9986(5)Å c=19.3145(7)Å
α=90.00° β=90.00° γ=90.00°
1-(1,1-dimethyl-1,2-dihydrobenzo[cd]indol-1-ium-2-yl)-4,4- dimethyl-2,6-dioxocyclohexan-1-ide
C21H23NO2
Organic & biomolecular chemistry (2012) 10, 38 7763-7779
a=9.6118(4)Å b=10.0248(6)Å c=18.7717(10)Å
α=90.00° β=103.180(3)° γ=90.00°
1-(1,1-dimethyl-1,2-dihydrobenzo[cd]indol-1-ium-2-yl)-2,6- dioxocyclohexan-1-ide monhydrate
C19H19NO2,H2O
Organic & biomolecular chemistry (2012) 10, 38 7763-7779
a=8.4223(2)Å b=9.4076(3)Å c=10.8996(3)Å
α=85.508(2)° β=73.336(2)° γ=68.462(2)°
1-(1,1-dimethyl-1,2-dihydrobenzo[cd]indol-1-ium-2-yl)-2,5 -dioxocyclopentan-1-ide monohydrate
C18H17NO2,H2O
Organic & biomolecular chemistry (2012) 10, 38 7763-7779
a=18.5849(7)Å b=9.1076(3)Å c=19.5453(8)Å
α=90.00° β=112.680(2)° γ=90.00°
C19H19N3O3
C19H19N3O3
Organic & biomolecular chemistry (2012) 10, 38 7763-7779
a=8.3360(4)Å b=8.7036(3)Å c=12.1220(6)Å
α=89.456(3)° β=85.190(2)° γ=65.248(3)°
1-(1!,1!-Diethyl-1!,2!-dihydrobenzo[cd]indol-1!-ium-2!-yl)-4,6- dioxo-1,3-dioxan-5-ide
C21H23NO4
Organic & biomolecular chemistry (2012) 10, 38 7763-7779
a=10.1338(3)Å b=16.0686(5)Å c=10.9554(4)Å
α=90.00° β=95.661(3)° γ=90.00°
1(1-(dimethylamino)naphth-8-yl)-2,2-bis(acetyl)ethene
C18H19NO2
Organic & biomolecular chemistry (2012) 10, 38 7763-7779
a=6.8270(4)Å b=8.7630(5)Å c=13.1899(7)Å
α=102.408(4)° β=98.689(4)° γ=94.696(3)°
1!-Ethyl-2,2,2!-trimethyl-2!,4!-dihydro-1!H-spiro((1,3)dioxane- 5,3!-naphtho[1,8-bc]azepine)-4,6-dione
C21H23NO4
Organic & biomolecular chemistry (2012) 10, 38 7763-7779
a=31.2818(6)Å b=7.09570(10)Å c=16.7814(3)Å
α=90.00° β=107.3740(10)° γ=90.00°
1-Ethyl-2-methyl-1,2-dihydronaphtho[1,8-bc]azepine-3,3(4H)-dicarbonitrile
C18H17N3
Organic & biomolecular chemistry (2012) 10, 38 7763-7779
a=15.0771(5)Å b=6.6633(2)Å c=15.5200(6)Å
α=90.00° β=109.378(4)° γ=90.00°
1!-Methyl-2!,4!-dihydro-1!H-spiro(indene-2,3!-naphtho[1,8-bc]azepine)-1,3-dione
C22H17NO2
Organic & biomolecular chemistry (2012) 10, 38 7763-7779
a=15.9448(12)Å b=7.7430(6)Å c=26.4365(18)Å
α=90.00° β=90.00° γ=90.00°
C22H17NO2
C22H17NO2
Organic & biomolecular chemistry (2012) 10, 38 7763-7779
a=8.8717(3)Å b=11.5384(3)Å c=15.6190(5)Å
α=90.00° β=95.980(3)° γ=90.00°
2-Hydroxy-1,1-dimethyl-1,2-dihydrobenzo[cd]indol-1-ium trifluoroacetate
C13H14NO,C2F3O2
Organic & biomolecular chemistry (2012) 10, 38 7763-7779
a=8.6837(3)Å b=12.8490(4)Å c=13.8588(5)Å
α=103.171(2)° β=93.108(2)° γ=106.795(2)°
1-hydroxynaphthalene-8-carbaldehyde cpd 15
C11H8O2
CrystEngComm (2011) 13, 23 6978
a=7.1576(5)Å b=29.301(3)Å c=7.6537(7)Å
α=90.00° β=91.699(4)° γ=90.00°
1,4-Di(methoxy)triptycene-9,10-dicarbaldehyde cpd 20
C24H18O4
CrystEngComm (2011) 13, 23 6978
a=14.0278(3)Å b=7.9798(2)Å c=15.6964(4)Å
α=90.00° β=96.197(2)° γ=90.00°
1,4-Dihydroxytriptycene-9,10-dicarbaldehyde acetonitrile solvate cpd 10.CH3CN
C24H17NO4
CrystEngComm (2011) 13, 23 6978
a=9.0118(3)Å b=9.6549(4)Å c=11.6967(5)Å
α=80.718(3)° β=87.782(3)° γ=65.542(2)°
1,4-Dihydroxytriptycene-9,10-dicarbaldehyde ethyl acetate solvate cpd 19.0.75ethyl acetate
C25H20O5.5
CrystEngComm (2011) 13, 23 6978
a=9.3754(7)Å b=9.6285(7)Å c=11.4470(9)Å
α=69.585(4)° β=69.800(4)° γ=77.586(4)°
9,10-Bis(1',3'-dioxolan-2'-yl)-1,4,4a,9a-tetrahydroanthracen-1,4-dione cpd 22
C26H22O6
CrystEngComm (2011) 13, 23 6978
a=21.837(2)Å b=9.2974(10)Å c=19.231(2)Å
α=90.00° β=100.008(3)° γ=90.00°
Lithium hemibenzoate
C14H11LiO4
CrystEngComm (2013) 15, 43 8823
a=5.3600(3)Å b=8.5693(7)Å c=13.4999(11)Å
α=98.830(4)° β=93.800(5)° γ=95.524(5)°
Rubidium hemibenzoate 6-coordinate polymorph 100 K
C14H11O4Rb
CrystEngComm (2013) 15, 43 8823
a=29.347(4)Å b=3.8697(5)Å c=11.3973(16)Å
α=90.00° β=95.478(7)° γ=90.00°
Sodium benzoate.2benzoic acid
C21H17NaO6
CrystEngComm (2013) 15, 43 8823
a=5.80770(10)Å b=14.4331(4)Å c=22.0139(6)Å
α=90.00° β=97.047(2)° γ=90.00°
Rubidium hemibenzoate 8 coordinate polymorph
C14H11O4Rb
CrystEngComm (2013) 15, 43 8823
a=29.0315(9)Å b=6.9630(2)Å c=6.6156(2)Å
α=90.00° β=99.297(2)° γ=90.00°
Cesium hemibenzoate monoclinic polymorph
C14H11CsO4
CrystEngComm (2013) 15, 43 8823
a=28.9095(8)Å b=7.0509(2)Å c=6.7779(2)Å
α=90.00° β=99.970(2)° γ=90.00°
2,2'-Diselenodibenzyl bromide
C14H12Br2Se2
Acta Crystallographica Section C (2009) 65, 8 o400-o403
a=11.4093(11)Å b=11.3589(11)Å c=24.176(2)Å
α=90.00° β=101.861(2)° γ=90.00°
2,2'-Diselenodibenzyl chloride
C14H12Cl2Se2
Acta Crystallographica Section C (2009) 65, 8 o400-o403
a=7.9160(2)Å b=8.02150(10)Å c=23.4689(4)Å
α=98.3880(10)° β=95.2870(10)° γ=90.6100(10)°
2,2'-(diselenodi-<i>o</i>phenylene)dimethanol
C14H14O2Se2
Acta Crystallographica Section C (2009) 65, 8 o400-o403
a=8.4461(2)Å b=8.9003(3)Å c=9.7427(3)Å
α=72.9040(10)° β=78.9500(10)° γ=76.9780(10)°
Potassium hemibenzoate
C14H11KO4
CrystEngComm (2013) 15, 43 8823
a=29.586(2)Å b=3.7964(3)Å c=11.1214(8)Å
α=90.00° β=97.096(9)° γ=90.00°
Cesium hemibenzoate orthorhombic phase
C14H11CsO4
CrystEngComm (2013) 15, 43 8823
a=28.3393(19)Å b=7.0215(3)Å c=6.9066(4)Å
α=90.00° β=90.00° γ=90.00°